113 related articles for article (PubMed ID: 6804290)
1. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
[TBL] [Abstract][Full Text] [Related]
2. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
Rezapkin G; Dragunsky E; Chumakov K
Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
[TBL] [Abstract][Full Text] [Related]
3. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
van der Marel P; Hazendonk AG; van Wezel AL
Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
[TBL] [Abstract][Full Text] [Related]
4. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
Rezapkin G; Martin J; Chumakov K
Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of poliovirus antigen measurements in vitro and in small animals.
von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
[No Abstract] [Full Text] [Related]
6. Killed poliovaccine: an evaluation of safety testing.
van Steenis G; van Wezel AL
Dev Biol Stand; 1981; 47():143-50. PubMed ID: 6262145
[TBL] [Abstract][Full Text] [Related]
7. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
9. Development of inactivated poliovirus vaccine derived from Sabin strains.
Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
[TBL] [Abstract][Full Text] [Related]
10. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
11. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
[TBL] [Abstract][Full Text] [Related]
12. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
[TBL] [Abstract][Full Text] [Related]
13. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
[TBL] [Abstract][Full Text] [Related]
14. Present state and developments in the production of inactivated poliomyelitis vaccine.
van Wezel AL
Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
[TBL] [Abstract][Full Text] [Related]
15. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
Montagnon BJ; Fanget B; Nicolas AJ
Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
[TBL] [Abstract][Full Text] [Related]
16. Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.
Ogra PL; Karzon DT
J Immunol; 1969 Jan; 102(1):15-23. PubMed ID: 4303877
[No Abstract] [Full Text] [Related]
17. Quality control for screening-assays by means of control charts: polio vaccine testing as an example.
Vogel I
Dev Biol Stand; 1996; 86():346. PubMed ID: 8785986
[No Abstract] [Full Text] [Related]
18. Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.
Crainic R; Horodniceanu F; Barme M
Dev Biol Stand; 1980; 46():275-9. PubMed ID: 6245003
[TBL] [Abstract][Full Text] [Related]
19. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats.
Doel TR; Osterhaus AD; van Wezel AL; van Steenis G
J Biol Stand; 1984 Jan; 12(1):93-9. PubMed ID: 6699027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]